Total Payments
$33,170
2024 Payments
$5,910
Companies
5
Transactions
40
Medicare Patients
1,374
Medicare Billing
$208,675
Payment Breakdown by Category
Consulting$16,900 (51.0%)
Other$14,110 (42.5%)
Food & Beverage$1,224 (3.7%)
Travel$935.47 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,900 | 9 | 51.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $8,150 | 5 | 24.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,865 | 2 | 17.7% |
| Food and Beverage | $1,224 | 11 | 3.7% |
| Travel and Lodging | $935.47 | 12 | 2.8% |
| Grant | $95.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Retrophin, Inc. | $27,015 | 35 | $0 (2019) |
| IDORSIA PHARMACEUTICALS US INC | $4,865 | 1 | $0 (2024) |
| Travere Therapeutics, Inc. | $1,150 | 2 | $0 (2024) |
| Boston Scientific Corporation | $95.00 | 1 | $0 (2018) |
| Novo Nordisk Health Care AG | $44.52 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,910 | 3 | IDORSIA PHARMACEUTICALS US INC ($4,865) |
| 2020 | $150.00 | 1 | Travere Therapeutics, Inc. ($150.00) |
| 2019 | $8,597 | 13 | Retrophin, Inc. ($8,597) |
| 2018 | $17,614 | 22 | Retrophin, Inc. ($17,519) |
| 2017 | $900.00 | 1 | Retrophin, Inc. ($900.00) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,865.00 | General |
| Category: Hypertension | ||||||
| 10/26/2024 | Novo Nordisk Health Care AG | — | Food and Beverage | In-kind items and services | $44.52 | General |
| 10/15/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 06/30/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Kidney Stones | ||||||
| 12/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 12/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Kidney Stones | ||||||
| 12/16/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $144.18 | General |
| Category: Kidney Stones | ||||||
| 08/22/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $34.80 | General |
| Category: Kidney Stones | ||||||
| 08/22/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $11.00 | General |
| Category: Kidney Stones | ||||||
| 08/22/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
| Category: Kidney Stones | ||||||
| 07/03/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 07/02/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $104.43 | General |
| Category: Kidney Stones | ||||||
| 04/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: Kidney Stones | ||||||
| 04/17/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 04/15/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $138.20 | General |
| Category: Kidney Stones | ||||||
| 01/14/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 01/10/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Kidney Stones | ||||||
| 08/23/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 08/22/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $370.00 | General |
| Category: Kidney Stones | ||||||
| 08/22/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $92.23 | General |
| Category: Kidney Stones | ||||||
| 08/01/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: Kidney Stones | ||||||
| 07/31/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
| 07/30/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $112.66 | General |
| Category: Kidney Stones | ||||||
| 06/05/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $25.07 | General |
| Category: Kidney Stones | ||||||
| 06/01/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 299 | 445 | $238,610 | $43,843 |
| 2022 | 7 | 429 | 682 | $367,013 | $67,285 |
| 2021 | 8 | 335 | 553 | $276,895 | $53,957 |
| 2020 | 8 | 311 | 483 | $226,999 | $43,589 |
Total Patients
1,374
Total Services
2,163
Medicare Billing
$208,675
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 98 | 144 | $84,844 | $16,628 | 19.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 109 | $45,098 | $10,911 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 81 | $33,858 | $6,153 | 18.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 38 | $38,318 | $5,408 | 14.1% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 12 | 30 | $18,510 | $2,168 | 11.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 15 | 24 | $12,536 | $1,358 | 10.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $5,446 | $1,218 | 22.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 229 | $91,538 | $20,057 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 92 | 141 | $76,547 | $17,355 | 22.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 65 | $64,025 | $10,871 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 72 | 87 | $37,910 | $6,833 | 18.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 21 | 58 | $35,018 | $4,279 | 12.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 53 | 67 | $33,827 | $4,009 | 11.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $28,148 | $3,882 | 13.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 81 | 208 | $80,062 | $18,367 | 22.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 76 | 110 | $60,411 | $13,510 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $40,101 | $7,571 | 18.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 49 | 67 | $32,693 | $4,159 | 12.7% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 23 | 52 | $29,732 | $3,876 | 13.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 43 | $18,442 | $3,748 | 20.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $11,491 | $1,767 | 15.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 12 | 13 | $3,963 | $959.20 | 24.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 170 | $63,335 | $15,408 | 24.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 58 | $49,666 | $9,891 | 19.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 65 | 112 | $53,281 | $7,050 | 13.2% |
About Anna Zisman
Anna Zisman is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1437317740.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Zisman has received a total of $33,170 in payments from pharmaceutical and medical device companies, with $5,910 received in 2024. These payments were reported across 40 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($16,900).
As a Medicare-enrolled provider, Zisman has provided services to 1,374 Medicare beneficiaries, totaling 2,163 services with total Medicare billing of $208,675. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Chicago, IL
- Active Since 05/23/2008
- Last Updated 10/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437317740
Products in Payments
- (815) Thiola (Drug) $27,165
- Tryvio (Drug) $4,865
- GENERAL KIDNEY STONE DISEASE (Device) $95.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Myles Wolf, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Internal Medicine $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Internal Medicine $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247